Tilray CEO: Alternatives in clinical cannabis are colossal

Tilray CEO: Alternatives in clinical cannabis are colossal

Tilray’s inventory is up this day, but mute down 80 percent from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon about the corporate’s…

Tilray CEO: There is a potential for growth by infusing whisky with cannabis

Tilray CEO: There is a potential for growth by infusing whisky with cannabis

Irwin Simon (Tilray CEO) joins “Closing Bell” to discuss the company’s acquisition of Breckenridge distillery and the possibility to infuse whiskey with cannabis. For access to live and exclusive video…

Tilray Are Looking Ahead To US Cannabis Legalization.

Tilray Are Looking Ahead To US Cannabis Legalization.

The cannabis sector is looking to the US to legalize cannabis at a federal level.The market for cannabis will be $100b according to Tilray CEO Irwin Simon.Tilray are well placed…

Tilray CEO Irwin Simon says that if cannabis is not legalized, companies will continue consolidating.

Tilray CEO Irwin Simon says that if cannabis is not legalized, companies will continue consolidating.

Irwin Simon from Tilray joins “Closing Bell” to talk about the company’s stock, and his outlook on marijuana regulation.